|
|
||||||||
24J
Q T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone1


*
Center for Neurologic Diseases, Brigham and Womens Hospital and Harvard Medical School, Boston, MA 02115; and
Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, and Cancer Immunology and AIDS, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115
NK T cells are a T cell subset in the human that express an
invariant
-chain (V
24invt T cells). Because of the
well-described immunomodulation by glucocorticoids on
activation-induced cell death (AICD), the effects of dexamethasone and
anti-CD3 stimulation on V
24invt T cell clones and
CD4+ T cell clones were investigated. Dexamethasone
significantly enhanced anti-CD3-mediated proliferation of
V
24invt T cells, whereas CD4+ T cells were
inhibited. Addition of neutralizing IL-2 Ab partially abrogated
dexamethasone-induced potentiation of V
24invt T cell
proliferation, indicating a role for autocrine IL-2 production in
corticosteroid-mediated proliferative augmentation. Dexamethasone
treatment of anti-CD3-stimulated V
24invt T cells did
not synergize with anti-Fas blockade in enhancing proliferation or
preventing AICD. The V
24invt T cell response to
dexamethasone was dependent on the TCR signal strength. In the presence
of dexamethasone, lower doses of anti-CD3 inhibited proliferation
of V
24invt T cells and CD4+ T cells; at
higher doses of anti-CD3, which caused inhibition of
CD4+ T cells, the V
24invt T cell clones
proliferated and were rescued from AICD. These results demonstrate
significant differences in TCR signal strength required between
V
24invt T cells and CD4+ cells, and suggest
important immunomodulatory consequences for endogenous and exogenous
corticosteroids in immune responses.
This article has been cited by other articles:
![]() |
M. D. Smithgall, M. R. Comeau, B.-R. Park Yoon, D. Kaufman, R. Armitage, and D. E. Smith IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells Int. Immunol., August 1, 2008; 20(8): 1019 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Chang, N. Liu, V. Klimek, H. Hassoun, A. Mazumder, S. D. Nimer, S. Jagannath, and M. V. Dhodapkar Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications Blood, July 15, 2006; 108(2): 618 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Kent, Y. Chen, S. M. Clemmings, V. Viglietta, N. S. Kenyon, C. Ricordi, B. Hering, and D. A. Hafler Loss of IL-4 Secretion from Human Type 1a Diabetic Pancreatic Draining Lymph Node NKT Cells J. Immunol., October 1, 2005; 175(7): 4458 - 4464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baecher-Allan and D. A. Hafler Suppressor T Cells in Human Diseases J. Exp. Med., August 2, 2004; 200(3): 273 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. J. van der Vliet, J. W. Molling, N. Nishi, A. J. Masterson, W. Kolgen, S. A. Porcelli, A. J. M. van den Eertwegh, B. M. E. von Blomberg, H. M. Pinedo, G. Giaccone, et al. Polarization of V{alpha}24+ V{beta}11+ Natural Killer T Cells of Healthy Volunteers and Cancer Patients Using {alpha}-Galactosylceramide-loaded and Environmentally Instructed Dendritic Cells Cancer Res., July 15, 2003; 63(14): 4101 - 4106. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |